Deutsches Ärzteblatt Hierfür sind Argatroban (nur intravenös), und Danaparoid (subkutan und intravenös) zugelassen. Fondaparinux wird in dieser Indikation nicht empfohlen, die Verabreichung dieses Wirkstoffs kann aber bei Zustand nach HIT und späterer Notwendigkeit zur ...
Seeking Alpha In spite of lowering our product revenue guidance, we are able to maintain our total revenue and margin guidance for 2013, primarily as a result of increased service revenue and increased royalties from Exela for the sale of argatroban projected for ...
Motley Fool The marketed products in the U.S. include Angiomax, Cleviprex, and Argatroban . Angiomax: Angiomax injection, an anticoagulant agent, is used to prevent the formation of blood clots that lead to heart attack or stroke. Argatroban : Used as an ... and more »
Marketwire (press release) The SMC's decision means that adult patients with suspected or confirmed heparin -induced thrombocytopenia type II (HIT) who require parenteral antithrombotic therapy, will now be able to more readily get access to Exembol® on the NHS in Scotland.
PharmaTimes ... in those with a predicted forced vital capacity less than or equal to 80%; and Mitsubishi Pharma's Exembol (argatroban), for anticoagulation in adult patients with heparin -induced thrombocytopenia type II who require parenteral anti-thrombotic therapy.
